DRLAX Mutual Fund

NAV$9.90

Fund Essentials - as of Jan 31, 2026

Net Assets
$9M
Expense Ratio
1.30%
Dividend Yield (Current)
2.47%
Holdings
107
Inception Date
Dec 29, 2006
Fund Family
BNY Mellon Investment Management
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+11.23%
1 Year+14.40%
3 Year+10.54%
5 Year+2.49%
10 Year+3.41%

Asset Allocation

Stocks: 99.10%
Cash: 0.71%
Other: 0.18%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
WELLWelltower Inc Health Care6.23%
EQIXEquinix, Inc.4.84%
PLDPrologis Inc4.65%
DLRDigital Realty Trust Inc3.54%
VTRVentas Canada Inc.3.22%
Top 10 Concentration: 34.67%Report Date: Jan 31, 2026
Download all 107 holdings for DRLAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
2.47%
Frequency
Annually
Latest Distribution
$0.81
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how DRLAX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$99/yr
7-day refund. Cancel anytime.
X-ray my whole portfolio
$99/yr Pro · 7-day refund. From MarketXLS, trusted since 2014.

DRLAX Mutual Fund Overview

DRLAX Mutual Fund (BNY Mellon Developed Markets Real Estate Securities Fund Class A) is managed by BNY Mellon Investment Management with $8.9M in net assets. DRLAX expense ratio is 1.30%, holding 107 positions across sectors including Real Estate, Unknown, Industrials. Inception date: 2006-12-29.

DRLAX performance shows a YTD return of 11.23%. The 1-year return is 14.40% and the 5-year return is 2.49%. DRLAX dividend yield stands at 2.47%, paid annually.

DRLAX top holdings include Welltower Inc Health Care (6.2%), Equinix, Inc. (4.8%), Prologis Inc (4.7%), Digital Realty Trust Inc (3.5%), Ventas Canada Inc. (3.2%). View all DRLAX holdings, sector breakdown, or dividend history.

DRLAX can be compared against other funds using the overlap calculator or side-by-side comparison tool. DRLAX alternatives are available via the screener, along with tax-loss harvesting opportunities.